CSwMR

Recommendations

Info

STAFF OF THE SCSPA 2012-13 Appendix A NATIONAL DIRECTOR Babakar Fall, Director General ANSD DEPUTY NATIONAL DIRECTOR Mamadou Falou MBENGUE, Deputy Director General ANSD TECHNICAL DIRECTOR Cheikh Tidiane NDIAYE, Director Social and Demographic Statistics TECHNICAL COORDINATOR Fatou Bintou NIANG CAMARA HEALTH EXPERT Dr. Ibou GUISSE OFFICIALS RESPONSIBLE FOR FIELD OPERATIONS Dr. Ibou GUISSE and Papa Mabèye DIOP OFFICIAL RESPONSIBLE FOR DATA PROCESSING Papa Thiécouta NDIAYE MANAGER Samba TALL STEERING AND TECHNICAL SUPERVISORY TEAM Mamadou Falou MBENGUE (ANSD), Cheikh Tidiane NDIAYE (ANSD), Fatou Bintou NIANG CAMARA (ANSD), Papa Mabeye DIOP (ANSD), Thiécouta NDIAYE (ANSD), Papa Ibrahima Sylmang SENE (ANSD), Dr. Moussa DIAKHATE (USAID), Abdoulaye GUEYE (UNICEF), Papa Madiop DIOP (UNFPA), Mariama GUEYE (IST/SIDA), Ndèye Khady TOURÉ (CLM), Matar CAMARA (USAID), Ibrahima NDAO (Micronutient Intiative), Julie THWING (PMI), Nafissatou DIOP (POPCOUNCIL), Doudou SENE (DNISS), Sokhna GAYE (DNISS), Malang COLY (WHO). ADAPTATION OF THE QUESTIONNAIRE AND TRAINING Dr Doudou SENE (DISS/MSAS), Oumou Kalsom GUEYE (DISS/MSAS), Amadou Bamba CISS (DISS/MSAS), Amadou DJIGUEUL (PNT), Dr Abdou Lahad MANGANE(PNA), Dr. Mamadou NDIAYE (Directorate of Medical Prevention), Dr Moussa DIA (Community Health Unit), Bintou Niang TOURE (Directorate of Reproductive Health and Child Survival), Malal KANTE (Directorate of Reproductive Health and Child Survival), Dr. Aida GADIAGA (Directorate of Reproductive Health and Child Survival), Adjaratou Sow DIALLO (Directorate of Reproductive Health and Child Survival) Moussa NDOUR (PNLP), Dr. Fatou NIASS (DLSI), Aicha DIOP DIAGNE (Directorate of Medical Prevention), Dr Awa Héléne DIOP (PNT), Souleymane NDIAYE (HOGGY), Dr. SENGHOR (Blood Bank) 53
Page 1:
Republic of Senegal SENEGAL Continu
Page 4 and 5:
This report presents the findings o
Page 7:
TABLES Table 2.1 Distribution of fa
Page 10 and 11:
ADMINISTRATIVE MAP OF SENEGAL viii
Page 12 and 13: 1.2 Objectives of the Survey The ob
Page 14 and 15: Table 2.1 Distribution of facilitie
Page 16 and 17: promotion of growth monitoring, gen
Page 19 and 20: 3 RESULTS 3.1 Availability of Basic
Page 21 and 22: Table 3.2 Availability of basic ame
Page 23 and 24: Table 3.3.2 Standard precautions fo
Page 25 and 26: Table 3.4.2 Laboratory diagnostic c
Page 27 and 28: Availability of Child Health Servic
Page 29 and 30: Growth monitoring at a frequency of
Page 31 and 32: Availability of Vaccines Table 3.9
Page 33 and 34: Table 3.10 Availability of family p
Page 35 and 36: Table 3.11.2 Methods of family plan
Page 37 and 38: Table 3.12.2 Methods of family plan
Page 39 and 40: Table 3.13.2 Availability of family
Page 41 and 42: Table 3.14 Availability of maternal
Page 43 and 44: Table 3.16 Availability of medicine
Page 45 and 46: The partograph, an essential item f
Page 47 and 48: Percentage of Facilities Which Offe
Page 49 and 50: Voluntary Counseling and Testing (V
Page 51 and 52: Table 3.22 Guidelines, trained staf
Page 53 and 54: 3.10 Non-Communicable Diseases The
Page 55 and 56: Table 3.25 Availability of essentia
Page 57 and 58: Medicines With regard to the availa
Page 59 and 60: Table 3.28 Availability of malaria
Page 61: Table 3.29 Availability of malaria
Page 65: QUESTIONNAIRES Appendix B 55
Page 68 and 69: 10/10/2012 2 of 85
Page 70 and 71: COORDONNEES GPS DE LA STRUCTURE SAN
Page 72 and 73: MODULE 1: INFORMATIONS GENERALES -
Page 74 and 75: MODULE 2: DISPONIBLITE DU SERVICE G
Page 76 and 77: SUPERVISION EXTERNE 350 Est-ce que
Page 78 and 79: SECTION 4: PERSONNELS- GESTION- OPI
Page 80 and 81: OPINIONS DES PATIENTS ET FEEDBACK 4
Page 82 and 83: SECTION 5: TRAITEMENT DES EQUIPEMEN
Page 84 and 85: 606 VERIFIEZ Q600 ET Q601 UTULISATI
Page 86 and 87: SALLE DE CONSULTATION A CE STADE, D
Page 88 and 89: DEPISTAGE DU VIH 806 Est-ce que la
Page 90 and 91: BIOCHIMIE 830 Est-ce qu'on fait n'i
Page 92 and 93: 848 Est-ce qu'on fait la COLORATION
Page 94 and 95: TUBERCULOSE 861 Est-ce qu'on fait d
Page 96 and 97: SECTION 9: MEDICAMENTS ET PRODUITS
Page 98 and 99: MEDICAMENTS ANTI-FONGIQUES 904 Est-
Page 100 and 101: SECTION 9.2: PRODUITS CONTRACEPTIFS
Page 102 and 103: SECTION 9.4: MEDICAMENTS ANTIRETROV
Page 104 and 105: CONDITIONS DE STOCKAGE DES ARV 945
Page 106 and 107: 1007 Est-ce que cette structure con
Page 108 and 109: SECTION 11: SERVICES DE SUIVI DE LA
Page 110 and 111: 07 Triage des enfants malades, c'es
Page 112 and 113:
SECTION 13: PLANIFICATION FAMILIALE
Page 114 and 115:
1315 VERIFIEZ Q1302.07 & Q1302.08.
Page 116 and 117:
SECTION 14: CONSULTATIONS PRENATALE
Page 118 and 119:
1420 OBSERVER POUR VOIR SI LES ACTI
Page 120 and 121:
SECTION 15: PREVENTION TRANSMISSION
Page 122 and 123:
PRECAUTIONS DE BASE 1550 VISITER LA
Page 124 and 125:
1609 Est-ce que vous avez les direc
Page 126 and 127:
1624 Est-ce que cette structure obs
Page 128 and 129:
Page 130 and 131:
SECTION 18: INFECTIONS SEXUELLEMENT
Page 132 and 133:
Page 134 and 135:
1913 Est-ce que le test de dépista
Page 136 and 137:
SECTION 20: TEST DE DEPISTAGE DU VI
Page 138 and 139:
SECTION 21: TRAITEMENT DU VIH 2100
Page 140 and 141:
SECTION 22: SOINS ET SERVICES DE SO
Page 142 and 143:
EQUIPEMENTS ET MATERIELS DE BASE 23
Page 144 and 145:
SECTION 24: SERVICES DE PETITE CHIR
Page 146 and 147:
SECTION 25: CESARIENNES 2500 VERIFI
Page 148 and 149:
SECTION 27: SERVICES DE TRANSFUSION
Page 150 and 151:
SECTION 30: NIVEAU GENERAL DE PROPR
Page 153 and 154:
10/10/2012 MEASURE DHS - ENQUETE SU
Page 155 and 156:
10/10/2012 201 VÉRIFIEZ A LA Q103
Page 157 and 158:
10/10/2012 3. SERVICES DE SANTE INF
Page 159 and 160:
10/10/2012 SERVICES D'ACCOUCHEMENT
Page 161 and 162:
10/10/2012 7. SERVICES DE DIAGNOSTI
Page 163:
10/10/2012 808 Parmi les diverses c
Page 166 and 167:
10/10/2012 4. OBSERVATION DE LA CON
Page 168 and 169:
10/10/2012 NO. QUESTIONS / OBSERVAT
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
4. OBSERVATION DE LA CONSULTATION D
Page 180 and 181:
NO. QUESTIONS / OBSERVATIONS AUTRES
Page 182 and 183:
NO. QUESTIONS / OBSERVATIONS 6. DIA
Page 184 and 185:
NO. 213 DÉSHYDRATATION QUESTIONS /
Page 186 and 187:
1. Informations Sur la Visite - PLA
Page 188 and 189:
NO. QUESTIONS CODES ALLER A 114 Le
Page 190 and 191:
2. Satisfaction de la cliente NO. Q
Page 192 and 193:
3. Caractéristiques Personnelles d
Page 194 and 195:
3. Informations sur la Visite NO. Q
Page 196 and 197:
NO. QUESTIONS CODES ALLER A TRAITEM
Page 198 and 199:
2. Satisfaction de l'accompagnateur
Page 200 and 201:
3. Caractéristiques Personnelles d
Page 202 and 203:
LISTE DU PERSONNEL CODE STRUCTURE C
Page 204 and 205:
LISTE DU PERSONNEL CODE STRUCTURE C
Page 206 and 207:
2 of 39
Page 208 and 209:
POSITIONNER LE GPS COORDONNEES GPS
Page 210 and 211:
MODULE 1: INFORMATIONS GENERALES -
Page 212 and 213:
MODULE 2: DISPONIBLITE DU SERVICE G
Page 214 and 215:
SUPERVISION EXTERNE 350 Est-ce que
Page 216 and 217:
SECTION 4: PERSONNELS- GESTION- OPI
Page 218 and 219:
SYSTEMES DE GESTION DES INFORMATION
Page 220 and 221:
SECTION 6: GESTION DES DECHETS MEDI
Page 222 and 223:
MATERIELS ET EQUIPEMENTS DE BASE (A
Page 224 and 225:
SECTION 8: DIAGNONSTIC 800 VERIFIEZ
Page 226 and 227:
MEDICAMENTS DEPARASITANTS 902 Est-c
Page 228 and 229:
SECTION 9.2: PRODUITS CONTRACEPTIFS
Page 230 and 231:
SECTION 11:SERVICES DE SUIVI DE LA
Page 232 and 233:
1210 Je voudrais savoir si les él
Page 234 and 235:
SECTION 13: PLANIFICATION FAMILIALE
Page 236 and 237:
SECTION 16: ACCOUCHEMENT ET SOINS A
Page 238 and 239:
Page 240 and 241:
SECTION 18: INFECTIONS SEXUELLEMENT
Page 242 and 243:
SECTION 30: NIVEAU GENERAL DE PROPR
Page 245:
REGISTRE DE MATERNITE Code de la st
Page 249 and 250:
PROMOTION DE LA CROISSANCE Code de
show all

CSwMR

Create successful ePaper yourself

Delete template?

Save as template?